Search research articles
Contact Us
Filters
Showing results (41-50 of 159) with videos related to
Page
of 16
Sort By:
Clinical & Translational Immunology
|
May 10, 2021
Categorisation of patients based on immune profiles: a new approach to identifying candidates for response to checkpoint inhibitors
Svetlana Bornschlegl, Michael P Gustafson, Danae A Delivanis, et al.
Scientific Reports
|
July 21, 2016
Quantification of Somatic Chromosomal Rearrangements in Circulating Cell-Free DNA from Ovarian Cancers
Faye R Harris, Irina V Kovtun, James Smadbeck, et al.
Thoracic Cancer
|
April 1, 2024
Personalized, tumor-informed, circulating tumor DNA assay for detecting minimal residual disease in non-small cell lung cancer patients receiving curative treatments
Youjin Oh, Sung Mi Yoon, Jeeyeon Lee, et al.
JCO Precision Oncology
|
January 8, 2025
Detecting Early Recurrence With Circulating Tumor DNA in Stage I-III Biliary Tract Cancer After Curative Resection
James Yu, Aiwu Ruth He, Mahmoud Ouf, et al.
JTO Clinical and Research Reports
|
February 24, 2025
Clinical Significance of Perioperative Minimal Residual Disease Detected by Circulating Tumor DNA in Patients With Lung Cancer With a Long Follow-up Data: An Exploratory Study
Shuta Ohara, Kenichi Suda, Sumedha Sudhaman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 11, 2017
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update
Ian Krop, Nofisat Ismaila, Fabrice Andre, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 20, 2014
Circulating tumor cell analysis in metastatic triple-negative breast cancers
Mark Jesus M Magbanua, Lisa A Carey, Amy DeLuca, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2019
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: ASCO Clinical Practice Guideline Update-Integration of Results From TAILORx
Fabrice Andre, Nofisat Ismaila, N Lynn Henry, et al.
Molecular Therapy. Methods & Clinical Development
|
September 12, 2022
Preclinical safety assessment of MV-s-NAP, a novel oncolytic measles virus strain armed with an <i>H</i> <i>.</i> <i>pylori</i> immunostimulatory bacterial transgene
Kimberly B Viker, Michael B Steele, Ianko D Iankov, et al.
Nature Cancer
|
July 5, 2022
Neoadjuvant study of niraparib in patients with HER2-negative, BRCA-mutated, resectable breast cancer
Laura M Spring, Hyo Han, Minetta C Liu, et al.
Page
of 16
Search research articles
Search
Showing results (41-50 of 159) with videos related to
Sort By:
Page
of 16
Clinical & Translational Immunology
|
May 10, 2021
Categorisation of patients based on immune profiles: a new approach to identifying candidates for response to checkpoint inhibitors
Svetlana Bornschlegl, Michael P Gustafson, Danae A Delivanis, et al.
Scientific Reports
|
July 21, 2016
Quantification of Somatic Chromosomal Rearrangements in Circulating Cell-Free DNA from Ovarian Cancers
Faye R Harris, Irina V Kovtun, James Smadbeck, et al.
Thoracic Cancer
|
April 1, 2024
Personalized, tumor-informed, circulating tumor DNA assay for detecting minimal residual disease in non-small cell lung cancer patients receiving curative treatments
Youjin Oh, Sung Mi Yoon, Jeeyeon Lee, et al.
JCO Precision Oncology
|
January 8, 2025
Detecting Early Recurrence With Circulating Tumor DNA in Stage I-III Biliary Tract Cancer After Curative Resection
James Yu, Aiwu Ruth He, Mahmoud Ouf, et al.
JTO Clinical and Research Reports
|
February 24, 2025
Clinical Significance of Perioperative Minimal Residual Disease Detected by Circulating Tumor DNA in Patients With Lung Cancer With a Long Follow-up Data: An Exploratory Study
Shuta Ohara, Kenichi Suda, Sumedha Sudhaman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 11, 2017
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update
Ian Krop, Nofisat Ismaila, Fabrice Andre, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 20, 2014
Circulating tumor cell analysis in metastatic triple-negative breast cancers
Mark Jesus M Magbanua, Lisa A Carey, Amy DeLuca, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2019
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: ASCO Clinical Practice Guideline Update-Integration of Results From TAILORx
Fabrice Andre, Nofisat Ismaila, N Lynn Henry, et al.
Molecular Therapy. Methods & Clinical Development
|
September 12, 2022
Preclinical safety assessment of MV-s-NAP, a novel oncolytic measles virus strain armed with an <i>H</i> <i>.</i> <i>pylori</i> immunostimulatory bacterial transgene
Kimberly B Viker, Michael B Steele, Ianko D Iankov, et al.
Nature Cancer
|
July 5, 2022
Neoadjuvant study of niraparib in patients with HER2-negative, BRCA-mutated, resectable breast cancer
Laura M Spring, Hyo Han, Minetta C Liu, et al.
Page
of 16